Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • For authors
    • Instructions for authors
    • Submit a manuscript
    • Author FAQs
    • Open access
    • COVID-19 submission information
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • For authors
    • Instructions for authors
    • Submit a manuscript
    • Author FAQs
    • Open access
    • COVID-19 submission information
  • Alerts
  • Podcasts
  • Subscriptions

COVID-19 and Smoking. Is Nicotine the Hidden Link?

Patrizia Russo, Stefano Bonassi, Robertina Giacconi, Marco Malavolta, Carlo Tomino, Fabrizio Maggi
European Respiratory Journal 2020; DOI: 10.1183/13993003.01116-2020
Patrizia Russo
1Clinical and Molecular Epidemiology, IRCSS San Raffaele Pisana, Rome, Italy
2Department of Human Sciences and Quality of Life Promotion, San Raffaele University, Rome, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stefano Bonassi
1Clinical and Molecular Epidemiology, IRCSS San Raffaele Pisana, Rome, Italy
2Department of Human Sciences and Quality of Life Promotion, San Raffaele University, Rome, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robertina Giacconi
3Advanced Technology Center for Aging Research, Scientific Technological Area, Italian National Institute of Health and Science on Aging (INRCA), Ancona, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marco Malavolta
3Advanced Technology Center for Aging Research, Scientific Technological Area, Italian National Institute of Health and Science on Aging (INRCA), Ancona, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Marco Malavolta
Carlo Tomino
4Scientific Direction, IRCSS San Raffaele Pisana, Rome, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fabrizio Maggi
5Departmentof Translational Research, University of Pisa, Pisa, Italy
6VirologyDivision, Pisa University Hospital, Pisa, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Nicotine via alpha7-nicotinic receptor induces ACE2 overexpression in Human Bronchial Epithelial Cells (HBEpC)

Leung et al. have recently published in the European Respiratory Journal a paper on the expression of ACE-2 in the small airway epithelia of smokers and COPD Patients, discussing its effects on the risk of severe COVID-19 [1]. The authors found an increased expression of the ACE-2 gene in the airways of subjects with COPD and in current smokers. Indeed, a recent systematic review reporting data on thesmoking habit of patients infected with Severe Acute Respiratory Syndrome Coronavirus (SARS CoV)-2, concluded that smoking may be likely associated with a negative progression of the disease and with the adverse outcome [2]. These conclusions were challenged in a correspondence published by Hua Cai on the basis that a reliable mechanism explaining this association was missing [3]. The need for these results to be supported by additional studies is quite clear, but we believe that a robust mechanistic explanation exists. Nicotine has a known influence on the homeostasis of the renin-angiotensin system (RAS) up-regulating the angiotensin-converting enzyme (ACE)/angiotensin (ANG)-II/ANG II type 1 receptor axis, and down-regulating the compensatory ACE2/ANG-(1–7)/Mas receptor axis, contributing in turn to the development of cardiovascular and pulmonary diseases [4]. Different airway cells, such as bronchial epithelial cells, type II alveolar epithelial cells, and interstitial fibroblasts lung, express nicotinic acetylcholine receptors (nAChR), specifically the α7subtype [5]. All these cells express components of the RAS [4].In addition, Nicotine increases the expression and/or activity of ACE in the lung [4], an increase which have been found also in the serum of smokers, and that required at least 20 min to return to control level [4]. ACE2 serves as a physiologically relevant cellular entry receptor for SARSCoV, for the human respiratory Coronavirus NL63, and probably for the (SARSCoV)-2 [6].The ACE binds the SARS CoV-2 S protein, and through its tissutal expression mediates the localisation and the efficiency of the infection [6].Moreover, Nicotine induces the epithelial-mesenchymal transition (EMT) [5, 7], a mechanism sufficient to allow “normal” differentiated cells to acquire the stem cell-like characteristics and properties. We planned experiments on human bronchial epithelial cells (HBEpC), obtained from Cell Applications Inc. (www.cellapplications.com/product no. 502K-05a).Cells were maintained as adherent monolayer in complete bronchial/tracheal epithelial cell growth medium (www.cellapplications.com/product) at 37°C in a 95% air/5% CO2, seeded at an initial density of 7.5×104 cells·cm−2, and sub-cultured with a 0.25% trypsin–1 mM EDTA solution (Sigma-Aldrich, Milan, Italy) when cultures reached 80% confluence. HBEpC are derived from the surface epithelium of normal human bronchi non-diseased (i.e. Asthma, COPD, or Type 2 Diabetes). The morphology is consistent with epithelial origin, and is positive for epithelial cell marker cytokeratin 18. Semi-confluent HBEpC at 4th passage (7.5×104 cells·cm−2) were treated:(a) for 1 h with zero or 1.0×10−7 M Nicotine (Sigma–Aldrich, Milan, Italy) dissolved in saline in complete medium; (b) with 1.0×10−6 M α-Bungarotoxin (α-BTX, Sigma–Aldrich, Milan, Italy)dissolved in saline, in the continued presence of nicotine at zero or 1.0×10−7 M for 1 h; (c) treated continuously with nicotine for additional passages, 1 passage every 48 h for a total of 16 passages. We showed, for the first time, that nicotine at 1×10−7 M (the concentration present on the alveolar lining fluids after one cigarette is in the range 6×10−6 to 6×10−5 M [5]is able to increase ACE2 (fig. 1a) in HBEpC. Treatment with nicotine induces phospho-S6 ribosomal protein (Ser235/236), Akt1, phospho-Akt (Ser473), phospho-Akt(Thr308) and phospho-p44/42 MAPK (Thr202/Tyr204) (fig. 1b).To verify the hypothesis that ACE2 is induced by nicotine through α7-nAChR, HBEpC, at 4th passage, in the exponential growth phase, plated at a density of 1×106 cells·mL−1, were incubated with α7-nAChR siRNA (0.1 μg) diluted in 100 μL of siRNA transfection medium. Transfection was performed as described by Li et al. [8], who transfected, successfully, HBE16 human airway epithelial cell line (unaffected cells).A clone of transfected HBEpC that did not express α7-nAChR proteins, also after treatment with nicotine, (fig. 1c) and is not able to induce phospho-S6 ribosomal protein (Ser235/236), Akt1, phospho-Akt (Ser473), phospho-Akt(Thr308) and phospho-p44/42 MAPK (Thr202/Tyr204) after nicotine treatment (fig. 1d), was selected for further experiments. Nicotine did not induce ACE2 in this clone (si-mRNA-α7-HBEpC) (fig. 1a). This observation supports the hypothesis that ACE2 increase is specifically mediated by α7-nAChR. Moreover, when HBEpC were incubated simultaneously with nicotine and α-BTX, an α7 nicotine antagonist [9], no induction of ACE2 was observed (fig. 1d). Importantly, treatment with Nicotine, α-BTX or with the combination is not cytotoxic (data not shown).On these bases, we suggest that smoking may promote cellular uptake mechanisms of SARS CoV-2 through α7-nAChR signalling.A possible α7-nAChR down-stream mechanism may be the induction of phospho-Akt and phospho-p44/42 MAPK. This mechanism was hypothesised, partially, by Olds and Kabbani on their schematic model explaining how nicotine exposure increases the risk of COVID-19 entry into lung cells [10]. α7-nAChRis present both in neuronal and non-neuronal cells (i.e. lung, endothelial, lymphocyte) consequently smoking may impact COVID-19 pathophysiology and clinical outcome in several organ systems including brain.

FIGURE 1
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 1

Effect of nicotine on HBEpC or si-mRNA-α7-HBEpC. Panel a) ACE2 detection. ACE2 was measured with Human ACE2 ELISA Kit ab235649 (www.abcam.com/human-ace2-elisa-kit-ab235649.html) according to manufacture instructions. Data are mean±se; p was evaluated using t-test. The green plots are the human ACE2 standard. Experiments were performed twice in triplicate. Panel b) Induction of phospho-S6 ribosomal protein (Ser235/236), Akt1, phospho-Akt (Ser473), phospho-Akt(Thr308) and phospho-p44/42 MAPK (Thr202/Tyr204) in HBEpC. Data were obtained using PathScan® cell growth Multi-target Sandwich ELISA kit n.7239 (Cell signalling) PathScan® Cell Growth Multi-Target Sandwich ELISA Kit is a solid phase sandwich enzyme linked immunosorbent assay (ELISA) that combines the reagents necessary to detect endogenous levels of S6 ribosomal protein, phospho-S6 ribosomal protein (Ser235/236), Akt1, phospho-Akt (Ser473), phospho-Akt(Thr308) and phospho-p44/42 MAPK (Thr202/Tyr204).Data are mean±se; p was evaluated using t-test. Experiments were performed twice in duplicate. Panel c) α7-nAChR protein detection. Western Blotting was performed as described previously [11]. Human α7-nAchR antibody NBP1-49348 was purchased by Novus Biologicals [www.novusbio.com]. 1–2 si-mRNA-α7-HBEpC treated with zero (lane 1) or 1.0×10−7 M Nicotine (lane 2) for 1 h. 3–4 HBEpC treated with zero (lane 3) or 1.0×10−7 M Nicotine (lane 4) for 1 h. Experiments were performed twice. Panel d) as in Panel (b), treated cells are si-mRNA-α7-HBEpC.

Footnotes

  • Conflict of interest: None to discose

  • Conflict of interest: None to disclose

  • Conflict of interest: None to disclose

  • Conflict of interest: None to disclose

  • Conflict of interest: None to disclose

  • Conflict of interest: None to disclose

  • Received April 10, 2020.
  • Accepted April 16, 2020.
  • Copyright ©ERS 2020
http://creativecommons.org/licenses/by-nc/4.0/

This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0.

References

  1. ↵
    1. Leung JM,
    2. Yang CX,
    3. Tam A, et al.
    ACE-2 Expression in the Small Airway Epithelia of Smokers and COPD Patients: Implications for COVID-19. Eur Resp J 2020: 2000688. Online ahead of print. doi:10.1183/13993003.00688-2020
  2. ↵
    1. Vardavas CI,
    2. Nikitara K
    . COVID-19 and smoking: A systematic review of the evidence. Tob Induc Dis 2020; 18: 20. doi:10.18332/tid/119324
    OpenUrlPubMed
  3. ↵
    1. Cai H
    . Sex difference and smoking predisposition in patients with COVID-19. Lancet Respir Med 2020; 8: e20. doi:10.1016/S2213-2600(20)30117-X
    OpenUrl
  4. ↵
    1. Oakes JM,
    2. Fuchs RM,
    3. Gardner JD, et al.
    Nicotine and the Renin-Angiotensin System. Am J Physiol Regul Integr Comp Physiol 2020; 315: R895–R906. doi:10.1152/ajpregu.00099.2018
    OpenUrl
  5. ↵
    1. Cardinale A,
    2. Nastrucci C,
    3. Cesario A, et al.
    Nicotine: specificrole in angiogenesis, proliferation and apoptosis. Crit Rev Toxicol 2012; 42: 68–89. doi:10.3109/10408444.2011.623150
    OpenUrlCrossRefPubMed
  6. ↵
    1. Zhou P,
    2. Yang XL,
    3. Wang XG, et al.
    A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 2020; 579: 270–273. doi:10.1038/s41586-020-2012-7
    OpenUrlCrossRefPubMed
  7. ↵
    1. Santoro A,
    2. Tomino C,
    3. Prinzi G, et al.
    Tobacco Smoking: Risk to Develop Addiction, Chronic Obstructive Pulmonary Disease, and Lung Cancer. Recent Pat Anticancer Drug Discov 2019; 14: 39–52. doi:10.2174/1574892814666190102122848
    OpenUrl
  8. ↵
    1. Li Q,
    2. Zhou X,
    3. Kolosov VP, et al.
    The Expression and Pharmacological Characterization of Nicotinic Acetylcholine Receptor Subunits in HBE16 Airway Epithelial Cells. Cell Biochem Biophys 2012; 62: 421–431. doi:10.1007/s12013-011-9324-z
    OpenUrlPubMed
  9. ↵
    1. Wang YY,
    2. Liu Y,
    3. Ni XY, et al.
    Nicotine promotes cell proliferation and induces resistance to cisplatin by α7 nicotinic acetylcholine receptor–mediated activation in Raw264.7 and El4 cells. Oncol Rep 2014; 31: 1480–1488. doi:10.3892/or.2013.2962
    OpenUrl
  10. ↵
    1. Olds JL,
    2. Kabbani N
    . Is nicotine exposure linked to cardiopulmonary vulnerability to COVID-19 in the general population? FEBS J 2020.
  11. ↵
    1. Trombino S,
    2. Cesaro A,
    3. Margaritora S, et al.
    Alpha7-nicotinic Acetylcholine Receptors Affect Growth Regulation of Human Mesothelioma Cells: Role of Mitogen-Activated Protein Kinase Pathway. Cancer Res 2004; 64: 135–145. doi:10.1158/0008-5472.CAN-03-1672
    OpenUrlAbstract/FREE Full Text
PreviousNext
Back to top
View this article with LENS
Vol 57 Issue 2 Table of Contents
European Respiratory Journal: 57 (2)
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
COVID-19 and Smoking. Is Nicotine the Hidden Link?
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Alerts
Sign In to Email Alerts with your Email Address
Citation Tools
COVID-19 and Smoking. Is Nicotine the Hidden Link?
Patrizia Russo, Stefano Bonassi, Robertina Giacconi, Marco Malavolta, Carlo Tomino, Fabrizio Maggi
European Respiratory Journal Jan 2020, 2001116; DOI: 10.1183/13993003.01116-2020

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
COVID-19 and Smoking. Is Nicotine the Hidden Link?
Patrizia Russo, Stefano Bonassi, Robertina Giacconi, Marco Malavolta, Carlo Tomino, Fabrizio Maggi
European Respiratory Journal Jan 2020, 2001116; DOI: 10.1183/13993003.01116-2020
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Ethical obligations for supporting healthcare workers during the COVID-19 pandemic
  • Is high-dose glucocorticoid beneficial in COVID-19? Response to Correspondence
  • BAL lymphocyte % is as good as the company it keeps
Show more Correspondence

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Reviewers
  • CME
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Submit a manuscript
  • ERS author centre

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2021 by the European Respiratory Society